Category: Home

DKA in gestational diabetes

DKA in gestational diabetes

The duration of DKA in gestational diabetes condition, the gestationxl type DKA in gestational diabetes T1D or T2D and antenatal Paleo diet foods medication doabetes documented in those with known diabeetes. The overall HbA1c was high at DKA presentation HbA1c: 9. This topic will discuss issues related specifically to DKA in pregnant patients. Dhanasekaran M, Mohan S, Erickson D, Shah P, Szymanski LM, Vella A, et al. Insulin glargine compared with Neutral Protamine Hagedorn insulin in the treatment of pregnant diabetics. Anti-tyrosine phosphatase antibodies.

Video

Diabetic ketoacidosis TOG

DKA in gestational diabetes -

Her pre-pregnancy BMI was Physical examination showed Kussmaul breathing with ketotic odor. The laboratory findings are summarized in Table 1.

Importantly, anion gap showed No obvious non-reassuring fetal status was recognized. At the time of admission to our hospital, her arterial pH was 7. Based on these findings, she was diagnosed as having DKA. In addition, diabetes-related antibodies including anti-glutamic acid decarboxylase GAD antibody and anti-tyrosine phosphatase IA-2 antibody were In view of the clinical course and these data, she was diagnosed as having DKA with adult-onset type 1 diabetes mellitus.

After diagnosis of DKA, treatment with saline and intensive insulin therapy was initiated immediately. After therapy, the blood glucose level returned to normal. Clinical course. Solid line shows change of fasting blood sugar FBS levels, broken line shows change of glycoalbumin GA levels, and chain line represents change of HbA1c levels.

FBS, fasting blood sugar; GA, glycoalbumin. After the ketoacidosis improved, she underwent diet therapy and intensive insulin therapy.

She was discharged from the hospital at 34 weeks of gestation. The course of pregnancy up to birth remained uneventful. At 38 weeks of gestation, she spontaneously delivered a healthy baby, which weighed 3. Her gestational weight gain was 3 kg. Mother has been receiving insulin therapy at the time of 1.

It is unusual for women with a normal GTT in the first trimester to develop type 1 diabetes mellitus later on during pregnancy. In most cases, the carbohydrate profile before or during pregnancy is unknown. However, at 11 weeks of gestation, our patient had normal glucose tolerance.

She developed DKA during the third trimester. To the best of our knowledge, this is the first case of a woman with normal glucose tolerance confirmed by g OGTT in the first trimester developing DKA in late pregnancy. Blood tests were positive for anti-GAD antibody and anti-islet cell antibody 2 ICA2.

Therefore, this patient manifested DKA as a result of pregnancy-related autoimmune diabetes. In this case, we focused on differential diagnosis.

Late pregnancy is characterized by a state of insulin resistance. The production of insulin antagonistic hormones such as human placental lactogen, prolactin, and cortisol contributes to insulin resistance. Furthermore, an inflammatory change in adipose tissue is associated with insulin resistance in late pregnancy 6.

Therefore, if DKA occurs during late pregnancy, careful diagnosis is required. There are at least three separate phenotypes of autoimmune diabetes in adults: latent autoimmune diabetes in adults LADA , adult-onset type 1 diabetes mellitus, and obese patients with phenotypic type 2 diabetes mellitus who are antibody positive type 1.

To standardize the definition of LADA, the Immunology of Diabetes Society proposed the following criteria: patients should be at least 30 years of age, positive for at least one of the four antibodies commonly found in type 1 diabetic patients anti-ICAs, anti-GAD65, anti-IA2, and anti-insulin , and should not have been treated with insulin within the first 6 months of diagnosis.

Fulminant type 1 diabetes mellitus is also a well-known cause of pregnancy-related DKA 8 , which is also a characteristic of non-autoimmune diabetes. Fulminant type 1 diabetes mellitus has a rapid onset followed by rapid development of DKA.

The level of HbA1c therefore remains nearly normal 9. However, antibodies, including ICAs, anti-GAD65, anti-IA-2, and anti-insulin, are absent in fulminant type 1 diabetes mellitus 9. Our patient had a high level of HbA1c and tested positive for antibodies, thereby ruling out fulminant type 1 diabetes mellitus.

After diet and insulin therapy, a target level of glucose could be achieved. In terms of insulin secretion, it is difficult to distinguish between adult type 1 diabetes mellitus and LADA. However, LADA presents clinically slow progression without ketoacidosis and weight loss Therefore, the present case was finally diagnosed as DKA with adult-onset type 1 diabetes mellitus.

In summary, DKA is associated with maternal and fetal mortality. If a patient complaints of general fatigue with urinary glucose and ketones in the latter half of gestation, the presence of DKA caused by the onset of diabetes should be considered, even if the patient showed normal glucose tolerance during the first trimester.

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

All the authors have read the manuscript and have approved this article. H Himuro is the author and T Sugiyama is the corresponding author of this article. H Nishigori, M Saito, J Sugawara, and S Nagase are clinicians who contributed to the management of this case.

N Yaegashi is a chief of the department in our hospital. Diabetes Care. Obstetrics and Gynecology Clinics of North America. Journal of Obstetrics and Gynaecology Research. American Journal of Obstetrics and Gynecology.

Journal of Molecular Endocrinology. Journal of Clinical Endocrinology and Metabolism. This topic will discuss issues related specifically to DKA in pregnant patients. Issues related to DKA in nonpregnant adults are reviewed separately.

Why UpToDate? Product Editorial Subscription Options Subscribe Sign in. Learn how UpToDate can help you. Select the option that best describes you. View Topic. Font Size Small Normal Large. Diabetic ketoacidosis in pregnancy. The goals of treatment are to prevent seizures, lower blood pressure to avoid maternal end-organ damage, and expedite delivery.

Women who develop severe preeclampsia prior to 23 weeks' gestation should be offered pregnancy termination because expectant management results in high maternal and perinatal morbidity and mortality.

For patients with severe preeclampsia at 24 to 34 weeks' gestation, current opinion is to either intervene delivery or pregnancy termination or expectantly manage existing symptoms. Odendaal et al and Sibai et al found improved perinatal outcomes with expectant management in selected patients with severe preeclampsia at 28 to 34 weeks' gestation.

Limited information about treatment options is available, as most studies evaluating treatment exclude patients with HELLP syndrome.

Most experts recommend prompt vaginal delivery within 48 hours, as cesarean delivery can increase the risk of bleeding because of low platelet count and reduced intravascular volume, which will adversely affect blood pressure.

Although these findings prolonged pregnancy, perinatal outcomes were not improved. Medications used to treat preeclampsia are presented in TABLE 2. Magnesium sulfate is the mainstay of therapy, as it prevents seizures by slowing neuromuscular conduction and depressing CNS irritability without affecting blood pressure.

Fetal monitoring parameters include heart rate, evidence of lung maturity, amniotic-fluid volume, and signs of fetal compromise. Corticosteroids such as betamethasone and dexamethasone can accelerate fetal lung maturity.

The use of corticosteroids may reduce the risk of neonatal respiratory distress syndrome, intravascular hemorrhage, infection, and death. Expectant management involves monitoring both mother and fetus closely and delaying delivery, when possible, to reduce neonatal complications TABLE 2.

Most patients improve after delivery and should be monitored for eclampsia for the next 48 hours. Patients should continue taking magnesium sulfate for 12 to 24 hours. Diabetic ketoacidosis DKA during pregnancy is a condition that necessitates emergent attention because of the significant negative consequences to the mother and the developing baby.

Diabetes first diagnosed during any trimester of pregnancy is classified as gestational diabetes. Ketoacidosis can occur in pregnancies complicated by type 1, type 2, or gestational diabetes.

Although type 1 pregnancy ketoacidosis is most common, patients with type 2 or gestational diabetes should be monitored for DKA throughout pregnancy.

Changes during pregnancy, such as increased insulin resistance, dehydration secondary to emesis, and stress, predispose the pregnant diabetic patient to DKA. Ketoacidosis most often presents during the second or third trimester, when insulin resistance is at its peak.

Several common precipitating factors include acute illness or infection, insulin-pump failure, noncompliance with the prescribed insulin regimen, and medication-induced ketoacidosis due to steroid or beta-adrenergic agonist use. Presenting symptoms of ketoacidosis in pregnant women are generally the same as in nonpregnant patients, but with aggressive onset.

Symptoms include nausea, vomiting, polyuria, polydypsia, and changes in mental status. Laboratory findings may include elevated anion gap, acidemia, hyperglycemia, ketonemia, or renal dysfunction. Because nausea, vomiting, and increased urinary frequency are common during pregnancy, women may minimize the significance of these symptoms and delay care.

Urine or blood ketone testing is recommended for pregnant women with diabetes who experience weight loss or are unable to maintain adequate oral intake owing to excessive nausea and vomiting.

Fetal effects of maternal DKA range from long-term cognitive deficits to fetal demise. Maternal DKA produces fetal distress through several complex mechanisms occurring simultaneously. Fetal hypoxia results from maternal volume depletion and acidemia.

The direct transfer of ketoacids across the placenta leads to fetal acidosis. Also, fetal hyperinsulinemia produces an increased oxygen demand in the fetus, worsening fetal distress. In addition, electrolyte imbalance--such as fetal hypokalemia--may place the fetus at risk for serious cardiac arrhythmia or arrest, and maternal hypophosphatemia leads to decreased oxygen delivery to the fetus.

Management of DKA in pregnant patients follows the same pattern as in nonpregnant patients, with the addition of fetal monitoring. Primary goals of therapy for the mother include rehydration; correction of metabolic acidosis; correction of electrolyte disturbances; blood glucose control; and finding and treating the precipitating cause of the DKA.

Effective management of maternal risk will reduce stress on the fetal environment and improve the chances of fetal preservation. Glucose targets for pregnant patients with diabetes are more aggressive than those for nonpregnant patients TABLE 3.

Once blood glucose is stable within target parameters and the patient is able to tolerate oral intake, the insulin infusion should be titrated off, with overlap of subcutaneous insulin initiation.

Diabetic ketoacidosis Cellulite reduction exercises for arms in gestarional is an obstetrical emergency associated DKA in gestational diabetes DK increased maternal and fetal mortality risk if not promptly identified and treated. Pregnancy Riabetes characterized bestational progressive insulin resistance, particularly throughout the second and third trimesters. The altered metabolic milieu during pregnancy means that DKA can develop more rapidly and at lower plasma glucose concentrations than observed outside of pregnancy, known as euglycemic DKA. Maheswaran Mahesh Dhanasekaran, M. Aoife M. Egan, M. This is comparable to the existing literature, which speaks to poor tolerance of the developing fetus to maternal acidosis. Fritha J. MorrisonMaryam Movassaghian diabettes, Ellen W. SeelyAshley CurranMaria ShubinaEmma Morton-EgglestonChloe A. ZeraJeffrey L. EckerFlorence M.

DKA in gestational diabetes -

Effective management of maternal risk will reduce stress on the fetal environment and improve the chances of fetal preservation.

Glucose targets for pregnant patients with diabetes are more aggressive than those for nonpregnant patients TABLE 3. Once blood glucose is stable within target parameters and the patient is able to tolerate oral intake, the insulin infusion should be titrated off, with overlap of subcutaneous insulin initiation.

Regular human insulin and Neutral Protein Hagedorn NPH insulin have been studied and utilized extensively in pregnancy, and have been found to be safe and effective. Aspart and lispro are also efficacious, safe options for short-acting insulin analogues, when necessary.

Effective management of preeclampsia and DKA can improve maternal and fetal morbidity and mortality. Pharmacists in acute or community settings can help recognize and facilitate the prompt management of these serious conditions in their patients.

Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Fam Physician. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications.

Am J Obstet Gynecol. Diagnosis, prevention, and management of eclampsia. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia.

Number 33, January Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Schneider MB, Umpierrez GE, Ramsey RD, et al. Pregnancy complicated by diabetic ketoacidosis: maternal and fetal outcomes. Diabetes Care. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin North Am.

Kamalakannan D, Baskar V, Barton DM, Abdu TA. Postgrad Med J. Tarif N, Al Badr W. Euglycemic diabetic ketoacidosis in pregnancy.

Saudi J Kidney Dis Transpl. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Standards of medical care in diabetes Executive summary: standards of medical care in diabetes Imbergamo MP, Amato MC, Sciortino G, et al.

Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume 7. Article Contents Abstract. Journal Article. THU A Presentation Of Diabetic Ketoacidosis In Gestational Diabetes.

Carly Yim, MD , Carly Yim, MD. Western University. Oxford Academic. Google Scholar. Selina Laura Liu, MD. Tamara Spaic, MD. St Joseph's Health Care. PDF Split View Views. Select Format Select format. ris Mendeley, Papers, Zotero. enw EndNote. bibtex BibTex. txt Medlars, RefWorks Download citation.

Permissions Icon Permissions. Close Navbar Search Filter Journal of the Endocrine Society This issue Endocrine Society Journals Endocrinology and Diabetes Books Journals Oxford Academic Enter search term Search. Abstract Disclosure: C. Presentation: Thursday, June 15, Published by Oxford University Press on behalf of the Endocrine Society.

For commercial re-use, please contact journals. To continue reading this article, you must sign in with your personal, hospital, or group practice subscription. Subscribe Sign in.

It does NOT include all information about conditions, treatments, medications, side effects, or risks that may apply to a specific patient.

It is not intended to be medical advice or a substitute for the medical advice, diagnosis, or treatment of a health care provider based on the health care provider's examination and assessment of a patient's specific and unique circumstances. Patients must speak with a health care provider for complete information about their health, medical questions, and treatment options, including any risks or benefits regarding use of medications.

This information does not endorse any treatments or medications as safe, effective, or approved for treating a specific patient. UpToDate, Inc. and its affiliates disclaim any warranty or liability relating to this information or the use thereof.

All rights reserved.

DKA in gestational diabetes C. Yim: None. Gestattional None. Spaic: None. In pregnancy, DKA more commonly occurs in diabehes DKA in gestational diabetes pre-existing diabetes, usually type 1 diabetes, and is exceptionally rare in women with gestational diabetes mellitus GDM. In her first pregnancy, she was diagnosed with GDM at 28 weeks, required treatment with metformin at 35 weeks, which she stopped postpartum.

Author: Nihn

0 thoughts on “DKA in gestational diabetes

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com